Quest Completes Athena Deal | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Quest Diagnostics today announced the completion of its acquisition of Athena Diagnostics from Thermo Fisher Scientific.

The $740 million deal was announced in late February.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.